Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3,934 CHF | -0.29% | +1.44% | +12.97% |
Apr. 18 | UBS Raises Givaudan to Neutral from Sell, Raises PT | MT |
Apr. 18 | GIVAUDAN : UBS raises its recommendation | CF |
Sales 2024 * | 7.19B 7.89B | Sales 2025 * | 7.54B 8.27B | Capitalization | 36.4B 39.97B |
---|---|---|---|---|---|
Net income 2024 * | 978M 1.07B | Net income 2025 * | 1.08B 1.19B | EV / Sales 2024 * | 5.62 x |
Net Debt 2024 * | 3.97B 4.36B | Net Debt 2025 * | 3.76B 4.13B | EV / Sales 2025 * | 5.33 x |
P/E ratio 2024 * |
37.2
x | P/E ratio 2025 * |
33.4
x | Employees | 16,260 |
Yield 2024 * |
1.8% | Yield 2025 * |
1.87% | Free-Float | 80.92% |
Latest transcript on Givaudan SA
1 day | -0.34% | ||
1 week | +1.68% | ||
Current month | -1.77% | ||
1 month | -2.98% | ||
3 months | +19.51% | ||
6 months | +38.81% | ||
Current year | +13.23% |
Managers | Title | Age | Since |
---|---|---|---|
Gilles Andrier
CEO | Chief Executive Officer | 63 | 01-09-30 |
Thomas Hallam
DFI | Director of Finance/CFO | 58 | 07-12-31 |
Investor Relations Contact | 45 | 23-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Olivier Filliol
BRD | Director/Board Member | 57 | 20-03-24 |
Tom Knutzen
BRD | Director/Board Member | 62 | - |
Calvin Grieder
CHM | Chairman | 68 | 13-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.39% | 121 M€ | -.--% | - | |
1.38% | 18 M€ | +2.56% | - | |
1.10% | 267 M€ | +6.56% | ||
1.02% | 49 M€ | +5.06% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 3,936 | -0.23% | 2 623 |
24-04-22 | 3,945 | -0.15% | 14,704 |
24-04-19 | 3,951 | +1.26% | 23,256 |
24-04-18 | 3,902 | +0.62% | 14,250 |
24-04-17 | 3,878 | -0.05% | 13,853 |
Delayed Quote Swiss Exchange, April 23, 2024 at 03:56 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.23% | 39.92B | |
+10.57% | 62.7B | |
-5.81% | 45.31B | |
+17.59% | 26.04B | |
+3.45% | 17.99B | |
-0.28% | 17.29B | |
+5.23% | 15.65B | |
-22.84% | 15.56B | |
-22.28% | 13.2B | |
-26.95% | 12.57B |
- Stock Market
- Equities
- GIVN Stock